Sandra Prior, PhD NIBSC

Dr. Sandra Prior joined NIBSC as Senior Scientist in 2015 working on the development of bioassay standards for therapeutic Monoclonal Antibodies (mAbs) and the investigation of structure-function in relation to the safety and efficacy of mAb products. She is also currently a member of the EDQM mAb working party expert committee. She has over 15 years’ experience in applied immunology and in vitro cell-based assay development. She obtained her PhD in 2000 from the University of Navarra (Spain) in collaboration with the Swiss Federal Institute of Technology (ETH-Zurich, Switzerland). Initially she worked in the field of bacterial vaccines investigating safety and protective mechanisms (NIBSC, Potters Bar, UK). In 2010, she joined Lonza Biologics (Cambridge, UK) where she worked as a Senior Scientist on bioactivity and immunogenicity assessment of biotherapeutics.